Dos pacientes murieron por marcapasos defectuosos el fabricante los vendió sabiéndolo | Noticias Univision Salud univision.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from univision.com Daily Mail and Mail on Sunday newspapers.
St. Jude Medical to pay $27M settlement for allegedly selling defective heart devices
Published
BALTIMORE, Md. (FOX 5 DC) - St. Jude Medical, Inc. has agreed to pay a $27 million settlement after allegations that they sold defective defibrillators for nearly two years, resulting in several injuries and deaths.
The lawsuit alleges that between November 2014 and October 2016, they sold the defective heart devices to health care facilities that were implanted into patients insured by federal healthcare programs such as Medicare and Medicaid.
The government contends that St. Jude knowingly caused the submission of false claims and failed to inform the FDA with critical information about prior injuries and a death which, had the FDA been made aware, would have led to a recall, said Acting United States Attorney Jonathan F. Lenzner.
By Reuters Staff
1 Min Read
WASHINGTON, July 8 (Reuters) - St. Jude Medical, which was acquired by Abbott Laboratories in 2017, has agreed to pay $27 million to settle allegations it knowingly sold defective heart devices, the U.S. Justice Department said on Thursday.
Reporting by Eric Beech; Editing by Mohammad Zargham
Abbott s St. Jude Medical To Pay $27 Mln To Settle Allegations Over Heart Devices
NORTH CHICAGO (dpa-AFX) - St. Jude Medical Inc. agreed to pay $27 million to settle allegations that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal health care programs, the U.S. Department of Justice said in a statement.
St. Jude was acquired by Abbott Laboratories in January 2017.
The U.S. alleged that St. Jude failed to disclose serious adverse health events in connection with the premature depletion of the battery in certain models of its Fortify, Fortify Assura, Quadra and Unify devices, which are implantable defibrillators used in patients at risk of cardiac arrest due to an irregular heartbeat.
St Jude Medical to pay $27M in DOJ settlement on heart devices startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.